Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19
Pros and cons factors influence population attitudes towards non-pharmaceutical interventions and vaccination during post-COVID-19
A neutralizing epitope on the SD1 domain of SARS-CoV-2 Spike targeted following infection and vaccination.